Koninklijke Philips N.V. NY Registry Shares - ADR Peer Comparison

$24.55

$0.10 (0.41%)

As on 24-Sep-2026 16:00EDT

Market cap

$24,123 Mln

Revenue (TTM)

$17,664 Mln

P/E Ratio

18.8

P/B Ratio

1.8

Div. Yield

4.1 %

Edit

	Koninklijke Philips N.V. NY Registry Shares - ADR	Align Technology (ALGN)	Bio-Rad Laboratories Inc. Class A (BIO)	Globus Medical (GMED)	Henry Schein (HSIC)
Market cap ($ Mln)	24,123	10,486	10,065	9,957	9,455
Revenue ($ Mln)	17,664	4,140	2,589	3,145	13,602
Net Profit ($ Mln)	1,114.00	413.58	222.40	535.46	403.00
Net Margin (%)	6.31	9.99	8.59	17.03	2.96
RoE (%)	9.93	9.99	3.04	11.46	11.87
Price to Earnings	18.84	25.99	45.79	19.21	24.81
Price-To-Book	1.83	2.51	1.43	2.12	3.00

Income Statement ($ Mln)

	Koninklijke Philips N.V. NY Registry Shares - ADR	Align Technology (ALGN)	Bio-Rad Laboratories Inc. Class A (BIO)	Globus Medical (GMED)	Henry Schein (HSIC)
Operating Revenue	17,664.00	4,139.53	2,589.30	3,144.90	13,602.00
Cost of Revenue	9,551.00	1,387.59	1,245.50	989.14	9,479.00
Gross Profit	8,058.00	2,756.90	1,343.60	1,981.10	3,842.00
Operating Expenses	6,392.00	2,200.16	1,108.90	1,504.66	3,349.00
Operating Profit (EBIT)	1,721.00	551.86	235.00	652.69	774.00
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	1,477.00	568.91	350.40	664.95	558.00
Provision for Tax	364.00	155.33	128.00	129.49	132.00
Profit after Tax (Net Income)	1,114.00	413.58	222.40	535.46	403.00
Minority Interest	-2.00	0.00	0.00	0.00	-23.00
Consolidated Profit	579.00	0.00	378.10	0.00	0.00

	Koninklijke Philips N.V. NY Registry Shares - ADR	Align Technology (ALGN)	Bio-Rad Laboratories Inc. Class A (BIO)	Globus Medical (GMED)	Henry Schein (HSIC)
Shareholder's Funds	11,447.00	4,232.45	7,173.90	4,768.60	3,157.00
Minority Interest	-2.00	0.00	0.00	0.00	-23.00
Non-Current Liabilities	7,802.00	276.53	2,116.80	240.31	3,170.00
Current Liabilities	7,423.00	1,908.60	961.30	479.35	3,488.00
Total Liabilities	26,944.00	6,233.69	10,576.50	5,302.76	11,215.00

	Koninklijke Philips N.V. NY Registry Shares - ADR	Align Technology (ALGN)	Bio-Rad Laboratories Inc. Class A (BIO)	Globus Medical (GMED)	Henry Schein (HSIC)
Non-Current Assets	17,371.00	3,754.53	7,231.50	3,272.75	6,781.00
Current Assets	9,330.00	2,663.05	3,020.50	2,215.51	4,600.00
Total Assets	26,944.00	6,233.69	10,576.50	5,302.76	11,215.00
Total Debt*	7,465.00	120.84	1,203.70	111.19	3,813.00
Net Current Assets	1,907.00	754.45	2,059.20	1,736.17	1,112.00

	Koninklijke Philips N.V. NY Registry Shares - ADR	Align Technology (ALGN)	Bio-Rad Laboratories Inc. Class A (BIO)	Globus Medical (GMED)	Henry Schein (HSIC)
Cash From Operating Activities	1,162.00	593.22	532.20	753.45	712.00
Cash Flow from Investing Activities	-737.00	-112.45	-189.70	-355.01	-477.00
Cash from Financing Activities	107.00	-464.58	-283.20	-679.16	-111.00
Net Cash Inflow / Outflow	--	--	--	--	--

	Koninklijke Philips N.V. NY Registry Shares - ADR	Align Technology (ALGN)	Bio-Rad Laboratories Inc. Class A (BIO)	Globus Medical (GMED)	Henry Schein (HSIC)
ROCE (%)	4.64	10.09	8.98	11.44	6.03
ROE (%)	9.93	9.99	3.04	11.46	11.87
ROA (%)	3.29	5.00	2.02	9.43	2.80
EBIT Margin (%)	10.30	15.19	-5.99	15.11	5.28
Net Margin (%)	6.31	9.99	8.59	17.03	2.96
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Koninklijke Philips N.V. NY Registry Shares - ADR	Align Technology (ALGN)	Bio-Rad Laboratories Inc. Class A (BIO)	Globus Medical (GMED)	Henry Schein (HSIC)
Revenue Growth (%)	-1.08	4.41	1.37	19.74	6.49
EBIT Growth (%)	59.79	-3.03	-131.06	36.96	8.46
Net Profit Growth (%)	587.65	-5.49	-30.32	50.14	3.60
EPS Growth (%)	579.15	-2.80	-29.66	50.51	10.35
Book Value Growth (%)	8.94	9.63	2.19	9.65	-1.75

	Koninklijke Philips N.V. NY Registry Shares - ADR	Align Technology (ALGN)	Bio-Rad Laboratories Inc. Class A (BIO)	Globus Medical (GMED)	Henry Schein (HSIC)
Price / Earnings	29.23	27.31	10.77	22.27	22.47
Price / Book Value	2.39	2.77	1.10	2.62	2.76
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	11.92	13.35	6.54	15.81	12.40
Market Cap ($ Cr)	--	--	--	--	--

	Koninklijke Philips N.V. NY Registry Shares - ADR	Align Technology (ALGN)	Bio-Rad Laboratories Inc. Class A (BIO)	Globus Medical (GMED)	Henry Schein (HSIC)
Debt to Equity	0.55	0.00	0.11	0.00	0.73
Short term debt to equity ratio	0.10	0.01	0.06	0.00	0.39
Current Ratio	1.26	1.40	3.14	4.62	1.32
Quick Ratio	0.82	1.28	2.33	2.93	0.73
Interest Coverage	5.06	364.75	8.18	97.52	4.51

	Koninklijke Philips N.V. NY Registry Shares - ADR	Align Technology (ALGN)	Bio-Rad Laboratories Inc. Class A (BIO)	Globus Medical (GMED)	Henry Schein (HSIC)
Debtors to sales (%)	20.36	27.74	17.06	23.51	12.96
Asset Turnover	0.52	0.50	0.24	0.55	0.95
Receivable days	73.75	99.00	65.39	82.15	43.40
Inventory Days	113.36	68.68	221.09	270.47	74.52
Payable days	70.18	32.89	37.02	33.17	41.37
Cash Conversion Cycle	116.92	134.79	249.46	319.45	76.55

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.